Tag: Europe
-
Covidien to Acquire Blood Vessel Device Developer
Covidien — a maker of medical devices, pharmaceuticals, and health care supplies based in Dublin, Ireland — agreed to acquire CV Ingenuity in Fremont, California, a developer of a device to treat peripheral artery disease. Financial terms of the deal, expected to be completed in the first quarter of 2013, were not disclosed. Peripheral artery…
-
U.K. Universities Form Advanced Materials Consortium
The universities of Manchester, Cambridge, and Lancaster in the U.K. received funding from the European Research Council to develop new two-dimensional materials similar to graphene. The €13.4 million ($US17.7 million) grant was awarded to the three institutions under the council’s Synergy Grant initiative. The universities will form what they call a Synergy Group to support…
-
University Research Leads to Battery Sorting Machine
Research on artificial intelligence by a professor at Gothenberg University in Sweden made possible a machine that sorts discarded household batteries and a company that developed and markets the system. Claes Strannegård, a researcher in logic and cognitive science at Gothenberg, applied his work on artificial intelligence to find a better way of sorting garbage.…
-
Kidney Stone Monitor Boosts Treatment Effectiveness
Engineers at University of Southampton in the U.K. tested a prototype monitoring device for ultrasound treatments of kidney stones that showed the device ready for full-scale clinical trials. The team led by Southampton engineering professor Tim Leighton published its findings yesterday online in the journal Proceedings of the Royal Society A (paid subscription required). In…
-
EU Approves Unitary Patent Regulations
The European Parliament in Strasbourg, France approved draft regulations establishing a common patent system for 25 participating member counties of the European Union. The approved regulations create a unitary patent instrument and govern the language versions of the patent documents. However, EU members Italy and Spain are not taking part in the program. The unitary…
-
DNA Sequencing Performed with Tiny Samples, No Library Prep
Researchers from the Wellcome Trust Sanger Institute and Babraham Institute, both in the U.K., developed a technique for sequencing DNA molecules requiring a tiny fraction of material and without the laborious library preparation that had been needed before. The work of the team led by Harold Swerdlow (pictured left), Sanger Institute research and development director,…
-
New Life Sciences Venture Fund to Invest in Europe, U.S.
Sofinnova Partners, a venture capital company in Paris, closed its seventh fund focusing on investments in life sciences start-up companies, valued at €240 million ($312 million). Sofinnova Partners is affiliated with Sofinnova Ventures, a life sciences venture capital company in Menlo Park, California. The company says contributors to the Sofinnova Capital VII fund are major…
-
Amgen Purchases Diagnostics Developer deCODE Genetics
Amgen, a biotechnology company in Thousand Oaks, California, acquired deCODE Genetics, a developer of genetic disease risk assessment tests in Reykjavik, Iceland in an all-cash transaction valued at $415 million. Amgen says the transaction does not require regulatory approval and is expected to close before the end of 2012. deCODE Genetics offers genetic scans for…
-
New Technique Developed for Stem Cell Delivery to Eyes
Engineers at University of Sheffield in the U.K. devised a new method for attaching stem cells to eyes that can lessen the need for tissue banks and reduce the growth of scar tissue on the eye. The technology, designed to treat damage to the cornea, the transparent layer on the front of the eye, is…
-
Report: Pharmas Increasing Medicine Access in Poor Regions
A foundation in the Netherlands reports that developing areas of the world have more access to drugs from the top 20 pharmaceutical companies than two years ago. The Access to Medicine Foundation that publishes a bi-annual index of drug access in developing regions says GlaxoSmithKline repeats in 2012 as the leading company in making its…